World CB & CDx- An interview with Dr Jude O’Donnell

Ahead of the digital 11th World Clinical Biomarkers & CDx Summit (Sept29– 30), Dr Jude O’Donnell spoke to World CB & CDx on her experience of planning ahead when it comes to clinical trial assay and CDx development and tying this to Dx performance, regulatory compliance and downstream success of a drug development program.

Read the full article below- total read time 10 minutes.

You can also register for World CB & CDx here.